Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-000892

Chief Financial Officer sold 10,000 shares at an average $39.24 ($392,409)

  • Chief Financial Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thunen Shelley B Chief Financial Officer 2024-01-02 Option exercise 10b5-1 +10,000 $15.60 $155,983 12,291 D
Thunen Shelley B Chief Financial Officer 2024-01-02 Sale 10b5-1 −4,519 $38.77 $175,191 7,772 D
Thunen Shelley B Chief Financial Officer 2024-01-02 Sale 10b5-1 −5,481 $39.63 $217,218 2,291 D
Derivatives
Thunen Shelley B Chief Financial Officer 2024-01-02 Option exercise · Stock Option (right to buy) 10b5-1 −10,000 66,805 D
Open-market sales · 10,000 sh · avg $39.24 · $392,409
Loading xslF345X05/ownership.xml…